62
Participants
Start Date
July 31, 2011
Primary Completion Date
December 31, 2014
Study Completion Date
January 31, 2015
Citalopram
Treatment with citalopram will be initiated at 20mg/day for the first 4 weeks (or one placebo capsule), followed by the option to increase the dose to 40mg per day (or two placebo capsules) for the remainder of the study period.
Placebo
Treatment with citalopram will be initiated at 20mg/day for the first 4 weeks (or one placebo capsule), followed by the option to increase the dose to 40mg per day (or two placebo capsules) for the remainder of the study period.
Avon and Wiltshire mental health partnership, Bristol
Derbyshire healthcare NHS foundation trust, Derby
Lincolnshire partnership NHS foundation trust, Lincoln
Camden and Islington NHS foundation trust, London
Central and North West London NHS foundation trust, London
Oxleas NHS foundation trust, London
South London and the Maudsley, London
Manchester health and social care trust, Manchester
Northumberland, Tyne and Wear NHS foundation trust, Newcastle
Oxfordshire and Buckinghamshire NHS foundation trust, Oxford
Sheffield social care foundation trust, Sheffield
South Staffordshire and Shropshire NHS foundation trust, Stafford
West london Mental Health Trust, London
Southern Health, Southampton
University of Manchester
OTHER
University of Southampton
OTHER
King's College London
OTHER
University of Oxford
OTHER
University College, London
OTHER
University of Bristol
OTHER
Imperial College London
OTHER